The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merus Labs International Inc

TSX: MSL
Delayed quote

$1.90

Today's change+0.07 +3.83%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.
 

Merus Labs International Inc

TSX: MSL
Delayed quote

$1.90

Today's change+0.07 +3.83%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Merus Labs International Inc crosses above 20-day moving average

Merus Labs International Inc closed up sharply Friday, rallying $0.07 or 3.83% to $1.90 and crossing above its 20-day moving average. Over the last five days, shares have lost 2.56% and are down 16.67% for the last year to date. This security has performed in-line with the S&P TSX during the last year.

Key company metrics

  • Trailing P/E1,428.57×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.00
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-0.49%

Merus Labs International Inc has a net profit margin of -0.49%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue16101311
Total other revenue--------
Total revenue16101311
Gross profit129119
Total cost of revenue4111
Total operating expense151099
Selling / general / administrative3332
Research & development--------
Depreciation / amortization7666
Interest expense (income), net operating--------
Unusual expense (income)0------
Other operating expenses, total--------
Operating income1042
Interest income (expense), net non-operating-2-1-1-2
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-120
Income after tax-1-220
Income tax, total-1000
Net income-1-220
Total adjustments to net income--------
Net income before extra. items-1-220
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-220
Inc. avail. to common incl. extra. items-1-220
Diluted net income-1-220
Dilution adjustment--00--
Diluted weighted average shares102958281
Diluted EPS excluding extraordinary itemsvalue per share-0.01-0.020.030.00
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.01-0.020.030.00